Genetic modification of bacteria to rapidly generate economcal vaccines for bacterial infections

Allan Saul of the Novartis Vaccines Institute for Global Health in Italy will genetically modify gram-negative bacteria to generate large quantities of their outer membranes, which can be loaded with antigens that stimulate immune responses. This technology could prove to be a reliable and economic platform for the generation of new vaccines.

Last update: October 05, 2023